FDA.reportPublic FDA data

Contrave (bupropion hydrochloride 90 MG / naltrexone hydrochloride 8 MG) 12 HR Extended Release Oral Tablet

RxCUI
1551474
RxNorm name
Contrave (bupropion hydrochloride 90 MG / naltrexone hydrochloride 8 MG) 12 HR Extended Release Oral Tablet
Display name
Contrave (bupropion hydrochloride 90 MG / naltrexone hydrochloride 8 MG) 12 HR Extended Release Oral Tablet
Full name
Contrave (bupropion hydrochloride 90 MG / naltrexone hydrochloride 8 MG) 12 HR Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Contrave Extended-ReleaseNALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDENalpropion Pharmaceuticals LLC485ff360-32c8-11df-928b-0002a5d5c51b2025-11-10Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1551474

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
485ff360-32c8-11df-928b-0002a5d5c51bContrave 8 MG / 90 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR bupropion hydrochloride 90 MG / naltrexone hydrochloride 8 MG Extended Release Oral Tablet [Contrave] [SBD] · Contrave (bupropion hydrochloride 90 MG / naltrexone hydrochloride 8 MG) 12 HR Extended Release Oral Tablet [SY]327These highlights do not include all the information needed to use CONTRAVE ® safely and effectively. See full prescribing information for CONTRAVE. CONTRAVE (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 201420251110
9889a75d-4197-496c-aae1-15c9058c1d1bContrave 8 MG / 90 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR bupropion hydrochloride 90 MG / naltrexone hydrochloride 8 MG Extended Release Oral Tablet [Contrave] [SBD] · Contrave (bupropion hydrochloride 90 MG / naltrexone hydrochloride 8 MG) 12 HR Extended Release Oral Tablet [SY]313These highlights do not include all the information needed to use CONTRAVE ® safely and effectively. See full prescribing information for CONTRAVE. CONTRAVE (naltrexone HCl and bupropion HCl) Extended-Release Tablets Initial U.S. Approval: 201420200118